Tracking treatment pathways in adult patients with hyperkalemia. - TRACK

Study identifier:D9480R00048

ClinicalTrials.gov identifier:NCT05408039

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

A prospective, non-interventional, longitudinal study of the treatment journey of adult patients with hyperkalemia

Medical condition

Hyperkalemia

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1297

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 14 Jul 2022
Estimated Primary Completion Date: 16 Dec 2024
Estimated Study Completion Date: 16 Dec 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria